Rita Mehta, MD of UC Irvine Health gives an overview of the PALOMA-1 trial and the use of palbociclib and letrozole in the treatment of ER+ and HER2-advanced breast cancer. This was recorded at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA.
Abstract 1001: Overall Survival: Palbociclib in Combination with Letrozole versus Letrozole Alone for Frontline Treatment of ER+/HER2-Advanced Breast Cancer PALOMA-1; TRIO-18
Advertisement